PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Regeneron scales up manufacturing, eyes human tests of COVID-19 antibody cocktail in June

As COVID-19 ravages across the globe, Regeneron has responded with its own two-pronged approach against the disease. After early results in China showed inhibiting...
Continue Reading →
News

With the world waiting, Roche socks $459M into COVID-19 antibody test production

Roche scored a major win with the FDA's backing for its COVID-19 antibody tests last week in a field marked by products of questionable quality. Now, to cover its bo...
Continue Reading →
News

Novartis, Incyte will take Jakafi into 2nd trial for COVID-19 patients on ventilators

Novartis and Incyte have already pitted their blockbuster JAK inhibitor Jakafi against COVID-19 as a possible treatment for a severe respiratory immune reaction. Now...
Continue Reading →
News

Turkish Cargo achieved the highest growth rate among the top 25 air cargo carriers

Turkish Cargo, the fastest growing air cargo brand in the world, achieved the highest growth rate among the best 25 air cargo carriers with 16.6 percent growth rate,...
Continue Reading →
News

Roche’s risdiplam shows promise in Type 1 SMA

One-year data from the FIREFISH Part 2 study, a global study evaluating Roche's risdiplam in infants aged one - seven months old with symptomatic Type 1 spinal muscu...
Continue Reading →
News

Blueprint’s Ayvakit fails to best Bayer’s Stivarga

Shares in Blueprint Medicines took a significant hit after it emerged that its Ayvakit (avapritinib) failed to best Bayer's Stivarga (regorafenib) in patients with g...
Continue Reading →
News

New system for capturing COVID-19 death toll in England

The government is introducing a new system for reporting data on COVID-19 deaths in order to capture a more accurate picture of the virus' toll. To date, only data...
Continue Reading →
News

National cancer director urges public to get symptoms checked during pandemic

As of this morning – Wednesday April 29 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 161,145 with 21,678 deaths. England’s nation...
Continue Reading →
News

ACG continues production to meet mission-critical pharmaceutical requirements in tackling COVID-19, with employee safety a top priority across its operations

Despite widespread disruption, ACG is continuing production in its factories across the world, and helping to keep supply chains running smoothly to meet mission-cri...
Continue Reading →
News

Opdivo/Cabometyx combo hits targets in first-line kidney cancer

Bristol Myers Squibb and Exelixis have announced that a late-stage study testing a combination of Opdivo (nivolumab) and Cabometyx (cabozantinib) has hit its primary...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026